Sensitivity to EGFR inhibitors based on location of EGFR exon 20 insertion mutations within the tyrosine kinase domain of EGFR.

被引:0
|
作者
Costa, Daniel Botelho
Yasuda, Hiroyuki
Sng, Natasha J.
Yeo, Wee-Lee
de Figueiredo-Pontes, Lorena Lobo
Tenen, Daniel G.
Kobayashi, Susumu
机构
[1] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Boston, MA 02215 USA
[2] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
7523
引用
收藏
页数:1
相关论文
共 50 条
  • [21] EGFR-A763_Y764insFQEA: A unique exon 20 insertion mutation that displays sensitivity to all classes of approved lung cancer EGFR tyrosine kinase inhibitors.
    Gergis, Carol
    Rangachari, Deepa
    Fujii, Masanori
    Varkaris, Andreas
    VanderLaan, Paul A.
    Kobayashi, Susumu
    Costa, Daniel Botelho
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [22] EGFR-A763 _Y764insFQEA Is a Unique Exon 20 Insertion Mutation That Displays Sensitivity to Approved and In-Development Lung Cancer EGFR Tyrosine Kinase Inhibitors
    Vasconcelos, Pedro E. N. S.
    Gergis, Carol
    Viray, Hollis
    Varkaris, Andreas
    Fujii, Masanori
    Rangachari, Deepa
    VanderLaan, Paul A.
    Kobayashi, Ikei S.
    Kobayashi, Susumu S.
    Costa, Daniel B.
    [J]. JTO CLINICAL AND RESEARCH REPORTS, 2020, 1 (03): : 1 - 8
  • [23] The Impact of On-Target Resistance Mediated by EGFR-T790M or EGFR-C797S on EGFR Exon 20 Insertion Mutation Active Tyrosine Kinase Inhibitors
    Kobayashi, Ikei S.
    Shaffer, William
    Viray, Hollis
    Rangachari, Deepa
    Vanderlaan, Paul A.
    Kobayashi, Susumu S.
    Costa, Daniel B.
    [J]. JTO CLINICAL AND RESEARCH REPORTS, 2024, 5 (01):
  • [24] Epidermal growth factor receptor (EGFR) exon 20 mutations in non-small-cell lung cancer and resistance to EGFR-tyrosine kinase inhibitors
    Hyun Sun Woo
    Hee Kyung Ahn
    Ha Yeon Lee
    Inkeun Park
    Young Saing Kim
    Junshik Hong
    Sun Jin Sym
    Jinny Park
    Jae Hoon Lee
    Dong Bok Shin
    Eun Kyung Cho
    [J]. Investigational New Drugs, 2014, 32 : 1311 - 1315
  • [25] Epidermal growth factor receptor (EGFR) exon 20 mutations in non-small-cell lung cancer and resistance to EGFR-tyrosine kinase inhibitors
    Woo, Hyun Sun
    Ahn, Hee Kyung
    Lee, Ha Yeon
    Park, Inkeun
    Kim, Young Saing
    Hong, Junshik
    Sym, Sun Jin
    Park, Jinny
    Lee, Jae Hoon
    Shin, Dong Bok
    Cho, Eun Kyung
    [J]. INVESTIGATIONAL NEW DRUGS, 2014, 32 (06) : 1311 - 1315
  • [26] Comparative clinical outcomes for patients with advanced NSCLC harboring EGFR exon 20 insertion mutations and common EGFR mutations
    Bazhenova, Lyudmila
    Minchom, Anna
    Viteri, Santiago
    Bauml, Joshua M.
    Ou, Sai-Hong Ignatius
    Gadgeel, Shirish M.
    Manuel Trigo, Jose
    Backenroth, Daniel
    Li, Tracy
    Londhe, Anil
    Mahadevia, Parthiv
    Girard, Nicolas
    [J]. LUNG CANCER, 2021, 162 : 154 - 161
  • [27] CtDNA assay to detect EGFR mutations and mechanisms of resistance to EGFR tyrosine kinase inhibitors.
    Bazhenova, Lyudmila
    Das, Satya
    Patel, Sandip Pravin
    Arnold, Lyle
    Singh, Veena M.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [28] A Novel Cell Line Model of EGFR Exon 20 Insertion Mutations
    Estrada-Bernal, Adriana
    Le, Anh T.
    Zhou, Hengbo
    Noonan, Sinead A.
    Aisner, Dara L.
    Camidge, D. R.
    Doebele, Robert C.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S341 - S341
  • [29] EGFR Exon 20 Insertion Mutations in Sinonasal Squamous Cell Carcinoma
    Pacini, Laura
    Cabal, Virginia N.
    Hermsen, Mario A.
    Huang, Paul H.
    [J]. CANCERS, 2022, 14 (02)
  • [30] Structural Mechanism and Inhibitors Targeting EGFR Exon 20 Insertion (Ex20ins) Mutations
    Chen, Hao
    Hu, Shiliang
    Patterson, Adam V.
    Smaill, Jeff B.
    Ding, Ke
    Lu, Xiaoyun
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2023, : 11656 - 11671